Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes.
Saved in:
| Title: | Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes. |
|---|---|
| Authors: | Xie C; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Centre of Research in Translating Nutritional Science to Good Health, Adelaide University, Adelaide, South Australia, Australia.; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia., White JB; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia., Huang W; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Centre of Research in Translating Nutritional Science to Good Health, Adelaide University, Adelaide, South Australia, Australia., Horowitz M; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Centre of Research in Translating Nutritional Science to Good Health, Adelaide University, Adelaide, South Australia, Australia.; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Rayner CK; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Centre of Research in Translating Nutritional Science to Good Health, Adelaide University, Adelaide, South Australia, Australia.; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Verjans JW; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia., Snel MF; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Mass Spectrometry Facility, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; School of Physics, Chemistry and Earth Sciences, College of Science, Adelaide University, Adelaide, South Australia, Australia., Psaltis PJ; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, Australia., Wu T; School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.; Centre of Research in Translating Nutritional Science to Good Health, Adelaide University, Adelaide, South Australia, Australia. |
| Source: | Diabetes [Diabetes] 2026 Apr 01; Vol. 75 (4), pp. 630-635. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1939-327X |
|---|---|
| DOI: | 10.2337/db25-0980 |
